Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver

Magnetic Resonance in Medicine

Volumn 60, Issue 4, 2008, Pages 796-802

  Chmelik M ^a,b   Schmid, A I ^a,b   Gruber, S ^b   Szendroedi, J ^a,c   Krssak M ^b   Trattnig, S ^b   Moser, E ^b   Roden, Michael ^a,c  

^a Karl Landsteiner Institute for Endocrinology and Metabolism   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HANUSCH HOSPITAL   (Austria)

Author keywords

31P metabolites; Absolute concentration; Concentration distribution; Human liver; Spectroscopic imaging

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOMOLECULES; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM;

ABSOLUTE QUANTIFICATION; CONCENTRATION DISTRIBUTIONS; HIGH SPATIAL RESOLUTION; HUMAN LIVER; INTRACELLULAR CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; SPECTROSCOPIC IMAGING; THREEDIMENSIONAL (3-D);

METABOLITES;

ADENOSINE TRIPHOSPHATASE; PHOSPHATASE; PHOSPHATE; PHOSPHODIESTERASE; PHOSPHORUS 31;

ADIABATICITY; ADULT; ARTICLE; CELLULAR DISTRIBUTION; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; LIVER METABOLISM; MALE; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTRUM; THREE DIMENSIONAL IMAGING;

EID: 53549119448     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21762     Document Type: Article

References (33)

1. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol (Gastrointest Liver Physiol) 2006;290:G852-G858.
2. Choi J, Ou J-HJ. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol (Gastrointest Liver Physiol) 2006;290:G847-G851.
3. Han D, Hanawa N, Saberi B, Kaplowitz N. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol (Gastrointest Liver Physiol) 2006;291:G1-G7.
4. Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance. Nat Clin Pract Endocrinol 2006;2:335-348.
5. Vanwassenaervanhall HN, Vandergrond J, Vanhattum J, Kooijman C, Hoogenraad TU, Mali WPTM. P-31 Magnetic resonance spectroscopy of the liver - correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 1995;21:443-449.
6. Lim AKP, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo P-31 MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003;37:788-794.
7. Menon DK, Harris M, Sargentoni J, Taylor-Robinson SD, Cox IJ, Morgan MY. In-vivo hepatic P-31 magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology 1995;108:776-788.
8. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Courts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in-vivo hepatic P-31 magnetic-resonance spectroscopy in cirrhosis - biochemical basis of spectral appearances. Hepatology 1995;21:417-427.
9. Changani KK, Jalan R, Cox IJ, Ala-Korpela M, Bhakoo K, Taylor-Robinson SD, Bell JD. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001;49:557-564.
10. Corbin IR, Ryner LN, Singh H, Minuk GY. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol (Gastrointest Liver Physiol) 2004;287:G379-G384.
11. 31P MR spectroscopy. Gastroenterology 2003;124:A755-A755.
12. Brinkmann G, Melchert UH, Dreher W, Brossmann J, Tressing H, Muhle C, Reuter M, Heller M. Application of the maximum-entropy method for evaluating phosphorus-31-magnetic resonance-spectra in patients with liver metastases. Invest Radiol 1995;30:150-155.
13. Kooby DA, Zakian KL, Challa SN, Matei C, Petrowsky H, Yoo HH, Koutcher JA, Fong YM. Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection. Cancer Res 2000;60:3800-3806.
14. Meyerhoff DJ, Karczmar GS, Matson GB, Boska MD, Weiner MW. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy. NMR Biomed 1990;3:17-22.
15. Buchli R, Meier D, Martin E, Boesiger P. Assessment of absolute metabolite concentrations in human tissue by P-31 MRS in-vivo. 2. Muscle, liver, kidney. Magn Reson Med 1994;32:453-458.
16. Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M. Understanding the discrepancies between P-31 MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 1998;16:205-211.
17. Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced P-31 NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 1996;9:141-155.
18. Tosner Z, Dezortova M, Tintera J, Hajek M. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. Magn Reson Mater Phys 2001;13:40-46.
19. Sijens PE, Vandijk P, Dagnelie PC, Oudkerk M. Non-T1-weighted P-31 chemical-shift imaging of the human liver. Magn Reson Imaging 1995;13:621-628.
20. Leij-Halfwerk S, Agteresch HJ, Sijens PE, Dagnelie PC. Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo P-31 magnetic resonance spectroscopy study. Hepatology 2002;35:421-424.
21. Nair S, Chacko VP, Arnold C, Diehl AM. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 2003;98:466-470.
22. Chmelík M, Gruber S, Schmid AI, Moser E, Roden M. Processing, quantification and visualization tool for spectroscopic imaging data. Proceedings of the annual meeting of the ESMRMB, 2006.
23. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magn Reson Mater Phys 2001;12:141-152.
24. Vanhamme L, Van Den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
25. Pohmann R, von Kienlin M. Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med 2001;45:817-826.
26. Buchli R, Boesiger P. Comparison of methods for the determination of absolute metabolite concentrations in human muscles by P-31 MRS. Magn Reson Med 1993;30:552-558.
27. 31P spectroscopy using the magnetization transfer experiment. NMR Biomed 2008;21:437-443.
28. Roth K, Hubesch B, Meyerhoff D, Naruse S, Gober L, Lawry T, Boska M, Weiner M. Non-invasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy. J Magn Reson 1989;81:299-310.
29. Rajanayagam V, Lee RR, Ackerman Z, Bradley WG, Ross BD. Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J Magn Reson Imaging 1992;2:183-190.
30. Murphy-Boesch J, Jiang H, Stoyanova R, Brown TR. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B-1 inhomogeneity. Magn Reson Med 1998;39:429-438.
31. Haase A, Hanicke W, Frahm J. The influence of experimental parameters in surface-coil NMR J Magn Reson 1984;56:401-412.
32. Hugg JW, Maudsley AA, Weiner MW, Matson GB. Comparison of it-space sampling schemes for multidimensional MR spectroscopic imaging. Magn Reson Med 1996;36:469-473.
33. Vikhoff-Baaz B, Starck G, Ljungberg M, Lagerstrand K, Forssell-Aronsson E, Ekholm S. Effects of k-space filtering and image interpolation on image fidelity in H-1 MRSI. Magn Reson Imaging 2001;19:1227-234.